Article Information
History
- August 30, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Daniala L. Weir, PhD1,*,
- Xiaomeng Ma, MSc2,3,
- Lisa McCarthy, MSc PharmD4,5,
- Terence Tang, MD4,6,
- Lauren Lapointe-Shaw, MD PhD7,8,
- Walter P. Wodchis, MD PhD2,3,
- Olavo Fernandes, PharmD8 and
- Emily G. McDonald, MD MSc9,10
- 1Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University
- 2Institute of Health Policy, Management and Evaluation, University of Toronto
- 3Health System Performance Network, Institute of Health Policy, Management & Evaluation, University of Toronto
- 4Institute for Better Health, Trillium Health Partners
- 5Department of Pharmacy, Trillium Health Partners
- 6Department of Internal Medicine, Trillium Health Partners
- 7Department of Medicine, University of Toronto
- 8University Health Network
- 9Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
- 10Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada
- ↵*Corresponding Author: Daniala Weir, PhD David De Weid Building Universiteitsweg 99 3584 CG Utrecht The Netherlands Email: d.l.weir{at}uu.nl
Posted August 30, 2022.
Medication Clusters at Hospital Discharge and Risk of Adverse Drug Events at 30-days Post-Discharge: A Population-based Cohort Study of Older Adults
